News
Sarepta, Gene Therapy
Digest more
Our Bureau, Mumbai Friday, July 18, 2025, 17:45 Hrs [IST] ...
The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...
Groundbreaking new research shows that it is possible to use gene therapy to restore hearing in both children and adults.
CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...
The Centers for Medicare and Medicaid Services (CMS) has selected 35 participants for its new, voluntary Cell and Gene ...
22h
InvestorsHub on MSNRocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene TherapyRocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results